WORCESTER, Mass.--(BUSINESS WIRE)--RXi Pharmaceuticals Corporation (RXi) [Nasdaq: RXII], today announced that Victor Ambros, Ph.D., Professor of Molecular Medicine at the University of Massachusetts Medical School, has been appointed to the Company’s Scientific Advisory Board, increasing the size of the Board to seven members.
